MMSI
Merit Medical Systems, Inc. · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +2 | 41.26M | $2.86B | +12 | −9 |
| Q1 2026 | 119 | +2 | 38.80M | $2.68B | +10 | −9 |
| Q4 2025 | 117 | -1 | 45.00M | $3.97B | +2 | −2 |
| Q3 2025 | 21 | +1 | 28.60M | $2.38B | +1 | −1 |
| Q2 2025 | 18 | 0 | 26.61M | $2.49B | +1 | −1 |
| Q1 2025 | 15 | -1 | 7.60M | $802.99M | +1 | −2 |
| Q4 2024 | 16 | 0 | 7.36M | $712.26M | +2 | −2 |
| Q3 2024 | 15 | +1 | 4.73M | $467.42M | +1 | — |
| Q2 2024 | 14 | — | 5.63M | $483.63M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.34M | — | $115.18M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.34M | — | $115.18M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (passive) | 782.73K | — | $67.28M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 780.48K | — | $67.08M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 780.48K | — | $67.08M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 634.61K | — | $54.54M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 630.40K | — | $54.18M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 630.40K | — | $54.18M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 300.00K | — | $25.79M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 248.16K | — | $21.33M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 218.46K | — | $18.78M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 214.85K | — | $18.47M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 204.52K | — | $17.58M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 117.91K | — | $10.13M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 117.91K | — | $10.13M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 95.41K | — | $8.20M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 48.27K | — | $4.15M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 11.04K | — | $949,146 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 11.04K | — | $949,146 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 11.04K | — | $949,146 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 398 holders, 58.87M shares, $3.96B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 7.50K sh · $678,360
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology